Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Cunningham Evan B.; Amin Janaki.; Feld Jordan J.; Bruneau Julie; Dalgard Olav; Powis Jeff; Hellard Margaret; Cooper Curtis; Read Phillip; Conway Brian; Dunlop Adrian J.; Norton Briana; Litwin Alain H.; Hajarizadeh Behzad; Thurnheer Maria Christine; Dillon John F.; Weltman Martin; Shaw David; Bruggmann Philip; Gane Edward; Fraser Chris; Marks Philippa; Applegate Tanya L.; Quiene Sophie; Siriragavan Sharmila; Matthews Gail V.; Dore Gregory J.; Grebely Jason

首页> 外文期刊>The International journal of drug policy >Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

【24h】

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

机译：依赖于慢性HCV感染和最近的注射药物的人们遵守Sofosbuvir和Velpatasvir：简化研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: This study investigated treatment adherence among people with recent injecting drug use in a study of sofosbuvir/velpatasvir therapy for HCV infection.

机译：背景：本研究在研究Sofosbuvir / VelpataSvir治疗中对近期注射药物用于HCV感染的药物使用治疗依从性。

著录项

来源
《The International journal of drug policy》 |2018年第2018期|共10页
作者
Cunningham Evan B.; Amin Janaki.; Feld Jordan J.; Bruneau Julie; Dalgard Olav; Powis Jeff; Hellard Margaret; Cooper Curtis; Read Phillip; Conway Brian; Dunlop Adrian J.; Norton Briana; Litwin Alain H.; Hajarizadeh Behzad; Thurnheer Maria Christine; Dillon John F.; Weltman Martin; Shaw David; Bruggmann Philip; Gane Edward; Fraser Chris; Marks Philippa; Applegate Tanya L.; Quiene Sophie; Siriragavan Sharmila; Matthews Gail V.; Dore Gregory J.; Grebely Jason;
展开▼
作者单位

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

Toronto Gen Hosp Toronto ON Canada;

Ctr Hosp Univ Montreal Montreal PQ Canada;

Akershus Univ Hosp Oslo Norway;

South Riverdale Community Hlth Ctr Toronto ON Canada;

Burnet Inst Melbourne Vic Australia;

Ottawa Hosp Res Inst Ottawa ON Canada;

UNSW Sydney Kirby Inst Sydney NSW Australia;

Vancouver Infect Dis Ctr Vancouver BC Canada;

Hunter New England Local Hlth Dist Drug &

Alcohol Clin Serv New Lambton Hts NSW Australia;

Montefiore Med Ctr New York NY USA;

Montefiore Med Ctr New York NY USA;

UNSW Sydney Kirby Inst Sydney NSW Australia;

Bern Univ Hosp Dept Infect Dis Bern Switzerland;

Univ Dundee Ninewells Hosp &

Med Sch Dundee Scotland;

Nepean Hosp Penrith NSW Australia;

Royal Adelaide Hosp Adelaide SA Australia;

Arud Ctr Addict Med Zurich Switzerland;

Auckland City Hosp Auckland New Zealand;

Coolaid Community Hlth Ctr Victoria BC Canada;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

UNSW Sydney Kirby Inst Sydney NSW Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
HCV; Treatment; PWID; Drug use; Injecting drug users; Compliance; OST; Blister pack; Stimulants; Amphetamine; Cocaine;

机译：HCV;治疗;PWID;药物使用;注射吸毒者;遵守;OST;泡罩包装;兴奋剂;Amphetamine;可卡因;

相似文献

外文文献
中文文献
专利

1. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study [J] . Cunningham Evan B., Amin Janaki., Feld Jordan J., The International journal of drug policy . 2018,第期

机译：依赖于慢性HCV感染和最近的注射药物的人们遵守Sofosbuvir和Velpatasvir：简化研究
2. A Randomized, Controlled, Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir/Velpatasvir for 12 Weeks in Direct Acting Antiviral-Experienced Patients with Genotype 1-6 HCV Infection: The POLARIS-4 Study [J] . Zeuzem Stefan, Flamm Steven L., Tong Myron J., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Sofosbuvir / Velpatasvir / Voxilaprevir或Sofosbuvir / Velpatasvir的随机，受控，第3阶段试验在直接代理抗病毒经验型患者的基因型1-6 HCV感染患者中进行12周：Polaris-4研究
3. O‐050: Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses [J] . Journal of viral hepatitis. . 2018,第S1期

机译：o-050：药物和酒精使用在近期注射药物使用的甲型肝炎病毒感染和VelpataSvir期间和含有Sofosbuvir和VelpataSvir的方法：从轨迹分析中的见解
4. Influence of hepatitis C virus genotypes and F protein on outcome of HCV infection among injection drug users [C] . Yun Zhang, Jingjing Yang, Haopeng Wang, International symposium on pharmacogenomics and the regulation of drug metabolism enzymes and genes. . 2010

机译：丙型肝炎病毒基因型和F蛋白对注射吸毒者HCV感染结局的影响
5. Molecular epidemiology and transmission dynamics of HCV infection in injection drug users in southern China. [D] . Tan, Yi. 2008

机译：中国南方注射吸毒者中HCV感染的分子流行病学和传播动力学。
6. Sofosbuvir–Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation [O] . Nisha Gaur, Vinay Malhotra, Dhananjai Agrawal, 2020

机译：Sofosbuvir-VelpataSvir固定药物组合用于治疗患者末期肾病和肾移植患者慢性丙型肝炎感染
7. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study [O] . Evan B. Cunningham, Janaki Amin, Jordan J. Feld, 2018

机译：依赖于慢性HCV感染和最近的注射药物的人群中的Sofosbuvir和Velpatasvir：简化研究

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

摘要

著录项

相似文献

相关主题

期刊订阅